Arteriosclerosis and Thrombosis, Vol 12, 701-707, Copyright © 1992 by American Heart Association

ARTICLES

A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study

HJ Parra, D Arveiler, AE Evans, JP Cambou, P Amouyel, A Bingham, D McMaster, P Schaffer, P Douste-Blazy and G Luc
SERLIA, Institut Pasteur, Lille, France.

The incidence of coronary heart disease (CHD) in middle-aged men is more than three times higher in Northern Ireland than in France. The ECTIM study, which is based on WHO MONICA centers in Belfast (Northern Ireland), Strasbourg (eastern France), Toulouse (southwestern France), and Lille (northern France), has been established to investigate this striking difference. Male patients aged 25-64 years with myocardial infarction (MI) and control subjects sampled from the general population were recruited in the four centers. Hypolipidemic drug treatment was much more frequent in France than in Belfast. "Hypercholesterolemia" defined by the presence of hypolipidemic drug treatment or a low density liproprotein cholesterol level greater than 200 mg/dl was more frequent in cases than in controls in both countries but was similar in both control groups. An in-depth study of lipid variables, including measurements of cholesterol fractions, triglycerides, apolipoproteins (apo), and lipoprotein particles (Lp), was performed in nonhypercholesterolemic subjects. In Northern Ireland and France, patients in comparison with controls had lower levels of high density lipoprotein cholesterol, apo A-I, apo A-II, Lp A-I, and Lp A-II:A-I and higher levels of Lp E:B and Lp(a):B. The levels of triglycerides, very low density lipoprotein cholesterol, apo B, and Lp C-III:B were higher in cases than in controls only in Belfast. In control subjects, the mean levels of cholesterol fractions and apolipoproteins were similar in Northern Ireland and France; however, the level of Lp A-I was lower and the levels of Lp E:B and Lp(a):B were higher in Northern Ireland than in France.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				R. Movva and D. J. Rader Laboratory Assessment of HDL Heterogeneity and Function Clin. Chem., May 1, 2008; 54(5): 788 - 800. [Abstract] [Full Text] [PDF]

				R. S. Birjmohun, G. M. Dallinga-Thie, J. A. Kuivenhoven, E. S.G. Stroes, J. D. Otvos, N. J. Wareham, R. Luben, J. J.P. Kastelein, K.-T. Khaw, and S. M. Boekholdt Apolipoprotein A-II Is Inversely Associated With Risk of Future Coronary Artery Disease Circulation, October 30, 2007; 116(18): 2029 - 2035. [Abstract] [Full Text] [PDF]

				P.-H. Groop, M. C. Thomas, M. Rosengard-Barlund, V. Mills, M. Ronnback, S. Thomas, C. Forsblom, M.-R. Taskinen, and G. Viberti HDL Composition Predicts New-Onset Cardiovascular Disease in Patients With Type 1 Diabetes Diabetes Care, October 1, 2007; 30(10): 2706 - 2707. [Full Text] [PDF]

				J. Delgado-Lista, F. Perez-Jimenez, T. Tanaka, P. Perez-Martinez, Y. Jimenez-Gomez, C. Marin, J. Ruano, L. Parnell, J. M. Ordovas, and J. Lopez-Miranda An Apolipoprotein A-II Polymorphism (-265T/C, rs5082) Regulates Postprandial Response to a Saturated Fat Overload in Healthy Men J. Nutr., September 1, 2007; 137(9): 2024 - 2028. [Abstract] [Full Text] [PDF]

				W. A. van der Steeg, G. K. Hovingh, A. H. E. M. Klerkx, B. A. Hutten, I. C. Nootenboom, J. H. M. Levels, A. van Tol, G. M. Dallinga-Thie, A. H. Zwinderman, J. J. P. Kastelein, et al. Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians J. Lipid Res., March 1, 2007; 48(3): 674 - 682. [Abstract] [Full Text] [PDF]

				V. Gajdos, F. M. Petit, C. Perret, A. Mollet-Boudjemline, P. Colin, L. Capel, V. Nicaud, A. Evans, D. Arveiler, F. Parisot, et al. Further Evidence That the UGT1A1*28 Allele Is Not Associated with Coronary Heart Disease: The ECTIM Study Clin. Chem., December 1, 2006; 52(12): 2313 - 2314. [Full Text] [PDF]

				S. Blankenberg, T. Godefroy, O. Poirier, H. J. Rupprecht, S. Barbaux, C. Bickel, V. Nicaud, R. Schnabel, F. Kee, C. Morrison, et al. Haplotypes of the Caspase-1 Gene, Plasma Caspase-1 Levels, and Cardiovascular Risk Circ. Res., July 7, 2006; 99(1): 102 - 108. [Abstract] [Full Text] [PDF]

				W. Koch, P. Hoppmann, J. C. Mueller, A. Schomig, and A. Kastrati Association of Transforming Growth Factor-{beta}1 Gene Polymorphisms With Myocardial Infarction in Patients With Angiographically Proven Coronary Heart Disease Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1114 - 1119. [Abstract] [Full Text] [PDF]

				B. F. Asztalos, D. Collins, L. A. Cupples, S. Demissie, K. V. Horvath, H. E. Bloomfield, S. J. Robins, and E. J. Schaefer Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2185 - 2191. [Abstract] [Full Text] [PDF]

				W Moore, F Kee, A. Evans, E. McCrum-Gardner, C Morrison, and H Tunstall-Pedoe Pre-hospital coronary care and coronary fatality in the Belfast and Glasgow MONICA populations Int. J. Epidemiol., April 1, 2005; 34(2): 422 - 430. [Abstract] [Full Text] [PDF]

				B. F. Asztalos, L. A. Cupples, S. Demissie, K. V. Horvath, C. E. Cox, M. C. Batista, and E. J. Schaefer High-Density Lipoprotein Subpopulation Profile and Coronary Heart Disease Prevalence in Male Participants of the Framingham Offspring Study Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 2181 - 2187. [Abstract] [Full Text] [PDF]

				D.-A. Tregouet, S. Ricard, V. Nicaud, I. Arnould, S. Soubigou, M. Rosier, N. Duverger, O. Poirier, S. Mace, F. Kee, et al. In-Depth Haplotype Analysis of ABCA1 Gene Polymorphisms in Relation to Plasma ApoA1 Levels and Myocardial Infarction Arterioscler Thromb Vasc Biol, April 1, 2004; 24(4): 775 - 781. [Abstract] [Full Text] [PDF]

				D. Sauvaget, V. Chauffeton, S. Dugue-Pujol, A.-D. Kalopissis, I. Guillet-Deniau, F. Foufelle, J. Chambaz, A. Leturque, P. Cardot, and A. Ribeiro In Vitro Transcriptional Induction of the Human Apolipoprotein A-II Gene by Glucose Diabetes, March 1, 2004; 53(3): 672 - 678. [Abstract] [Full Text] [PDF]

				G. Luc, J.-M. Bard, J. Ferrieres, A. Evans, P. Amouyel, D. Arveiler, J.-C. Fruchart, P. Ducimetiere, and on behalf of the PRIME Study Group Value of HDL Cholesterol, Apolipoprotein A-I, Lipoprotein A-I, and Lipoprotein A-I/A-II in Prediction of Coronary Heart Disease: The PRIME Study Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1155 - 1161. [Abstract] [Full Text] [PDF]

				F. Fumeron, D. Betoulle, V. Nicaud, A. Evans, F. Kee, J.-B. Ruidavets, D. Arveiler, G. Luc, and F. Cambien Serotonin Transporter Gene Polymorphism and Myocardial Infarction: Etude Cas-Temoins de l'Infarctus du Myocarde (ECTIM) Circulation, June 25, 2002; 105(25): 2943 - 2945. [Abstract] [Full Text] [PDF]

				M. T. Montoya, A. Porres, S. Serrano, J. C. Fruchart, P. Mata, J. A. G. Gerique, and G. R. Castro Fatty acid saturation of the diet and plasma lipid concentrations, lipoprotein particle concentrations, and cholesterol efflux capacity Am. J. Clinical Nutrition, March 1, 2002; 75(3): 484 - 491. [Abstract] [Full Text] [PDF]

				L. Tiret, O. Poirier, V. Nicaud, S. Barbaux, S.-M. Herrmann, C. Perret, S. Raoux, C. Francomme, G. Lebard, D. Tregouet, et al. Heterogeneity of linkage disequilibrium in human genes has implications for association studies of common diseases Hum. Mol. Genet., February 1, 2002; 11(4): 419 - 429. [Abstract] [Full Text] [PDF]

				F. Schiele, M. Vincent-Viry, M. Starck, B. Beaud, G. Hennache, G. Siest, S. Visvikis, and B. Herbeth Apolipoprotein E in Apolipoprotein B (apo B)- and Non-apo B-containing Lipoproteins in 3523 Participants in the Stanislas Cohort: Biological Variation and Genotype-specific Reference Limits Clin. Chem., February 1, 2002; 48(2): 291 - 300. [Abstract] [Full Text] [PDF]

				F. M. van 't Hooft, G. Ruotolo, S. Boquist, U. de Faire, G. Eggertsen, and A. Hamsten Human Evidence That the Apolipoprotein A-II Gene Is Implicated in Visceral Fat Accumulation and Metabolism of Triglyceride-Rich Lipoproteins Circulation, September 11, 2001; 104(11): 1223 - 1228. [Abstract] [Full Text] [PDF]

				S.-M. Herrmann, H. Funke-Kaiser, K. Schmidt-Petersen, V. Nicaud, M. Gautier-Bertrand, A. Evans, F. Kee, D. Arveiler, C. Morrison, H.-D. Orzechowski, et al. Characterization of Polymorphic Structure of Cathepsin G Gene: Role in Cardiovascular and Cerebrovascular Diseases Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1538 - 1543. [Abstract] [Full Text] [PDF]

				L.-C. Lyu, C.-Y. Yeh, A. H Lichtenstein, Z. Li, J. M Ordovas, and E. J Schaefer Association of sex, adiposity, and diet with HDL subclasses in middle-aged Chinese Am. J. Clinical Nutrition, July 1, 2001; 74(1): 64 - 71. [Abstract] [Full Text] [PDF]

				B. F. Asztalos, P. S. Roheim, R. L. Milani, M. Lefevre, J. R. McNamara, K. V. Horvath, and E. J. Schaefer Distribution of ApoA-I-Containing HDL Subpopulations in Patients With Coronary Heart Disease Arterioscler Thromb Vasc Biol, December 1, 2000; 20(12): 2670 - 2676. [Abstract] [Full Text] [PDF]

				S.-M. Herrmann, C. Whatling, E. Brand, V. Nicaud, J. Gariepy, A. Simon, A. Evans, J.-B. Ruidavets, D. Arveiler, G. Luc, et al. Polymorphisms of the Human Matrix Gla Protein (MGP) Gene, Vascular Calcification, and Myocardial Infarction Arterioscler Thromb Vasc Biol, November 1, 2000; 20(11): 2386 - 2393. [Abstract] [Full Text] [PDF]

				R. W. Mahley, J. Pépin, K. E. Palaoglu, M. J. Malloy, J. P. Kane, and T. P. Bersot Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase: high density lipoprotein characterization and gender-specific effects of apolipoprotein E genotype J. Lipid Res., August 1, 2000; 41(8): 1290 - 1301. [Abstract] [Full Text]

				J F Albucher, J Ferrieres, J B Ruidavets, B Guiraud-Chaumeil, B P Perret, and F Chollet Serum lipids in young patients with ischaemic stroke: a case-control study J. Neurol. Neurosurg. Psychiatry, July 1, 2000; 69(1): 29 - 33. [Abstract] [Full Text] [PDF]

				C. Dachet, O. Poirier, F. Cambien, J. Chapman, and M. Rouis New Functional Promoter Polymorphism, CETP/-629, in Cholesteryl Ester Transfer Protein (CETP) Gene Related to CETP Mass and High Density Lipoprotein Cholesterol Levels : Role of Sp1/Sp3 in Transcriptional Regulation Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 507 - 515. [Abstract] [Full Text] [PDF]

				J.-C. Lambert, T. Brousseau, V. Defosse, A. Evans, D. Arveiler, J.-B. Ruidavets, B. Haas, J.-P. Cambou, G. Luc, P. Ducimetiere, et al. Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations--the ECTIM Study Hum. Mol. Genet., January 1, 2000; 9(1): 57 - 61. [Abstract] [Full Text] [PDF]

				P. L. Colvin, E. Moriguchi, P. H. R. Barrett, J. S. Parks, and L. L. Rudel Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates J. Lipid Res., October 1, 1999; 40(10): 1782 - 1792. [Abstract] [Full Text]

				J. S. Cohn, C. Marcoux, and J. Davignon Detection, Quantification, and Characterization of Potentially Atherogenic Triglyceride-Rich Remnant Lipoproteins Arterioscler Thromb Vasc Biol, October 1, 1999; 19(10): 2474 - 2486. [Abstract] [Full Text] [PDF]

				L. Tiret, O. Poirier, V. Hallet, T. A. McDonagh, C. Morrison, J. J. V. McMurray, H. J. Dargie, D. Arveiler, J.-B. Ruidavets, G. Luc, et al. The Lys198Asn Polymorphism in the Endothelin-1 Gene Is Associated With Blood Pressure in Overweight People Hypertension, May 1, 1999; 33(5): 1169 - 1174. [Abstract] [Full Text] [PDF]

				E. Brand, S.-M. Herrmann, V. Nicaud, J.-B. Ruidavets, A. Evans, D. Arveiler, G. Luc, P.-F. Plouin, L. Tiret, and F. Cambien The 825C/T Polymorphism of the G-Protein Subunit ß3 Is Not Related to Hypertension Hypertension, May 1, 1999; 33(5): 1175 - 1178. [Abstract] [Full Text] [PDF]

				B. Zhang, S. Ye, S.-M. Herrmann, P. Eriksson, M. de Maat, A. Evans, D. Arveiler, G. Luc, F. Cambien, A. Hamsten, et al. Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary Atherosclerosis Circulation, April 13, 1999; 99(14): 1788 - 1794. [Abstract] [Full Text] [PDF]

				D. Moatti, P. Seknadji, C. Galand, O. Poirier, F. Fumeron, S. Desprez, M. Garbarz, D. Dhermy, D. Arveiler, A. Evans, et al. Polymorphisms of the Tissue Factor Pathway Inhibitor (TFPI) Gene in Patients With Acute Coronary Syndromes and in Healthy Subjects : Impact of the V264M Substitution on Plasma Levels of TFPI Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 862 - 869. [Abstract] [Full Text] [PDF]

				S.-M. Herrmann, O. Poirier, V. Nicaud, A. Evans, J.-B. Ruidavets, G. Luc, D. Arveiler, C. Bao-Sheng, and F. Cambien Identification of two polymorphisms in the promoter of the microsomal triglyceride transfer protein (MTP) gene: lack of association with lipoprotein profiles J. Lipid Res., December 1, 1998; 39(12): 2432 - 2435. [Abstract] [Full Text]

				J. Dallongeville, J.-C. Fruchart, P. Maigret, S. Bertolini, G. Bittolo Bon, M. M. Campbell, M. Farnier, J. Langan, G. Mahla, P. Pauciullo, et al. Double-Blind Comparison of Apolipoprotein and Lipoprotein Particle Lowering Effects of Atorvastatin and Pravastatin Monotherapy in Patients With Primary Hypercholesterolemia Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(2): 103 - 110. [Abstract] [PDF]

				M. Tilly-Kiesi, A. H. Lichtenstein, J. Joven, E. Vilella, M. C. Cheung, W. V. Carrasco, J. M. Ordovas, G. Dolnikowski, and E. J. Schaefer Impact of Gender on the Metabolism of Apolipoprotein A-I in HDL Subclasses LpAI and LpAI:AII in Older Subjects Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3513 - 3518. [Abstract] [Full Text]

				P. S. Bachorik, K. L. Lovejoy, M. D. Carroll, and C. L. Johnson Apolipoprotein B and AI distributions in the United States, 1988–1991: results of the National Health and Nutrition Examination Survey III (NHANES III) Clin. Chem., December 1, 1997; 43(12): 2364 - 2378. [Abstract] [Full Text] [PDF]

				J. H. Stein and R. S. Rosenson Lipoprotein Lp(a) Excess and Coronary Heart Disease Arch Intern Med, June 9, 1997; 157(11): 1170 - 1176. [Abstract] [PDF]

				B. Agerholm-Larsen, B. G. Nordestgaard, R. Steffensen, T. I.A. Sorensen, G. Jensen, and A. Tybjærg-Hansen ACE Gene Polymorphism: Ischemic Heart Disease and Longevity in 10 150 Individuals: A Case-Referent and Retrospective Cohort Study Based on the Copenhagen City Heart Study Circulation, May 20, 1997; 95(10): 2358 - 2367. [Abstract] [Full Text]

				M. Tilly-Kiesi, A. H. Lichtenstein, J. M. Ordovas, G. Dolnikowski, R. Malmstrom, M.-R. Taskinen, and E. J. Schaefer Subjects With ApoA-I(Lys107->0) Exhibit Enhanced Fractional Catabolic Rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI With AII) Arterioscler Thromb Vasc Biol, May 1, 1997; 17(5): 873 - 880. [Abstract] [Full Text]

				P. Alaupovic, W. J. Mack, C. Knight-Gibson, and H. N. Hodis The Role of Triglyceride-Rich Lipoprotein Families in the Progression of Atherosclerotic Lesions as Determined by Sequential Coronary Angiography From a Controlled Clinical Trial Arterioscler Thromb Vasc Biol, April 1, 1997; 17(4): 715 - 722. [Abstract] [Full Text]

				F. Cambien, S. Ricard, A. Troesch, C. Mallet, L. Generenaz, A. Evans, D. Arveiler, G. Luc, J.-B. Ruidavets, and O. Poirier Polymorphisms of the Transforming Growth Factor-ß1 Gene in Relation to Myocardial Infarction and Blood Pressure: The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study Hypertension, November 1, 1996; 28(5): 881 - 887. [Abstract] [Full Text]

				H.-O. Mowri, J. R. Patsch, A. M. Gotto Jr, and W. Patsch Apolipoprotein A-II Influences the Substrate Properties of Human HDL2 and HDL3 for Hepatic Lipase Arterioscler Thromb Vasc Biol, June 1, 1996; 16(6): 755 - 762. [Abstract] [Full Text]

				I. Behague, O. Poirier, V. Nicaud, A. Evans, D. Arveiler, G. Luc, J.-P. Cambou, P.-Y. Scarabin, L. Bara, F. Green, et al. ß Fibrinogen Gene Polymorphisms Are Associated With Plasma Fibrinogen and Coronary Artery Disease in Patients With Myocardial Infarction : The ECTIM Study Circulation, February 1, 1996; 93(3): 440 - 449. [Abstract] [Full Text]

				M. Tilly-Kiesi, Z. Qiuping, S. Ehnholm, J. Kahri, S. Lahdenpera, C. Ehnholm, and M.-R. Taskinen ApoA-IHelsinki (Lys107->0) Associated With Reduced HDL Cholesterol and LpA-I:A-II Deficiency Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1294 - 1306. [Abstract] [Full Text]

				I. C. Klausen, U. Beisiegel, H.-J. Menzel, M. Rosseneu, V. Nicaud, and O. Faergeman Apo(a) Phenotypes and Lp(a) Concentrations in Offspring of Men With and Without Myocardial Infarction : The EARS Study Arterioscler Thromb Vasc Biol, August 1, 1995; 15(8): 1001 - 1008. [Abstract] [Full Text]

				M. Syvanne, J. Kahri, K. S. Virtanen, and M.-R. Taskinen HDLs Containing Apolipoproteins A-I and A-II (LpA-I:A-II) as Markers of Coronary Artery Disease in Men With Non–Insulin- Dependent Diabetes Mellitus Circulation, August 1, 1995; 92(3): 364 - 370. [Abstract] [Full Text]

				K. Ikewaki, L. A. Zech, M. Kindt, H. B. Brewer Jr, and D. J. Rader Apolipoprotein A-II Production Rate Is a Major Factor Regulating the Distribution of Apolipoprotein A-I Among HDL Subclasses LpA-I and LpA-I:A-II in Normolipidemic Humans Arterioscler Thromb Vasc Biol, March 1, 1995; 15(3): 306 - 312. [Abstract] [Full Text]

				T. O'Brien, T. T. Nguyen, B. J. Hallaway, D. Hodge, K. Bailey, D. Holmes, and B. A. Kottke The Role of Lipoprotein A-I and Lipoprotein A-I/A-II in Predicting Coronary Artery Disease Arterioscler Thromb Vasc Biol, February 1, 1995; 15(2): 228 - 231. [Abstract] [Full Text]